Skip to main content
. 2014 Jun 3;6:597–603. doi: 10.2147/IJWH.S59852

Table 2.

Patient characteristics, including physical age (years), menarche age (years), duration of contraceptive use (months), blood pressure profile (mmHg), BMI (kg/m2); lipid profile (mmol/L) CV risk indices of the C, OC, IC, and IMP contraceptive groups

Test parameter C (n=24) OC (n=19) IC (n=47) IMP (n=5) P-value
Age (years) 29.25±8.09 33.11±6.32 29.91±5.48 32.2±5.97 NS
Menarche age (years) 16.07±2.56 16.38±3.56 16.81±0.52 16.2±0.73 NS
Duration of use (months) 94.63±19.62 43.64±7.85 83.4±10.6 NS
SBP (mmHg) 113.04±1.89 117.32±3.71 116.49±2.13 131.20±10.35 NS
DBP (mmHg) 68.75±1.81*,† 77.11±2.80 78.57±1.97* 87.4±10.6 0.019*/0.025
BMI (kg/m2) 21.73±0.75*,† 26.4±1.12* 25.24±0.63 22.30±0.94 0.003*/0.008
TC (mmol/L) 3.35±0.62*,† 4.33±0.96* 4.00±0.91 3.77±0.66 0.002*/0.018
TG (mmol/L) 0.66±0.24 0.83±0.31 0.80±0.51 0.82±0.12 NS
HDLC (mmol/L) 1.31±0.25 1.3±0.25 1.35±0.39 1.20±0.26 NS
LDLC (mmol/L) 1.74±0.57*,† 2.65±0.94* 2.29±0.80 2.21±0.80 0.002*/0.039
VLDLC (mmol/L) 0.31±0.11 0.38±0.14 0.36±0.23 0.37±0.06 NS
TC/HDLCa 2.63±0.13* 3.46±0.27* 3.12±0.13 3.32±0.47 0.026*
LDLC/HDLCb 1.39±0.56* 2.15±1.05* 1.82±0.76 2.00±0.96 0.014*
Log (TG/HDLC)c −0.33±0.25 −0.22±0.22 −0.27±0.26 −0.16±0.15 NS

Notes:

a

Castelli risk index I

b

Castelli risk index II

c

atherogenic risk index

*,†

P<0.05; reference intervals: TC =3.60−6.20 mmol/L; TGs =0.40−2.25 mmol/L; direct HDLC =1.03−1.55 mmol/L; LDLC =0−3.90 mmol/L; VLDLC <0.65 mmol/L; Castelli risk =0.00−4.40; blood pressure =110/70 mmHg; BMI (kg/m2) <18.5 (underweight), 18.5−24.9 (normal weight), >25 (obesity).

Abbreviations: BMI, body mass index; C, control group; CV, cardiovascular; DBP, diastolic blood pressure; HDLC, high-density lipoprotein cholesterol; IC, injectable contraceptive; IMP, implant; LDLC, low-density lipoprotein cholesterol; NS, not significant; OC, oral contraceptive; SBP, systolic blood pressure; TC, total cholesterol; TG, triglyceride; VLDLC, very-low-density lipoprotein cholesterol.